| Health / Medical Topics |
Ocrelizumab
A Fc-modified, humanized monoclonal antibody directed against the B-cell CD20 cell surface antigen, with immunosuppressive activity. Ocrelizumab binds to CD20 on the surfaces of B-cells, triggering complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) of B-cells overexpressing CD20. The CD20 antigen, a non-glycosylated cell surface phosphoprotein that acts as a calcium ion channel, is found on over 90% of B-cells, B-cell lymphomas, and other lymphoid tumor cells of B-cell origin; it plays an important role in B-cell functioning. (NCI Thesaurus)
YOU MAY ALSO LIKE
A disorder characterized by bluish-black discoloration of the cartilaginous tissues due to accumulation of homogentisic acid. It is associated with alkaptonuria. Signs…
A species of aerobic, Gram-negative, rod shaped bacteria assigned to the phylum Proteobacteria. This species is motile with 1 to 3 polar…
A species of aerobic, Gram-negative, rod shaped bacteria assigned to the phylum Proteobacteria. This species is motile using peritrichous flagella, catalase, urease…
A genus of aerobic, Gram negative, rod shaped bacterium assigned to the phylum Proteobacteria and the family Brucellaceae.
A white, crystalline powder that is very unstable in the presence of light but fairly heat resistant. Ochratoxin A is a widespread,…
An indication or description that an event occurs concurrently with a substance overdose.
